Target
Phospholipase A2, membrane associated
Ligand
BDBM23753
Substrate
BDBM23751
Meas. Tech.
Fluorimetric Assay
pH
7.5±n/a
Temperature
295.15±n/a K
IC50
5080±n/a nM
Citation
 Boukli, LTouaibia, MMeddad-Belhabich, NDjimdé, APark, CHKim, JJYoon, JHLamouri, AHeymans, F Design of new potent and selective secretory phospholipase A2 inhibitors. Part 5: synthesis and biological activity of 1-alkyl-4-[4,5-dihydro-1,2,4-[4H]-oxadiazol-5-one-3-ylmethylbenz-4'-yl(oyl)] piperazines. Bioorg Med Chem 16:1242-53 (2008) [PubMed]  Article 
Target
Name:
Phospholipase A2, membrane associated
Synonyms:
GIIC sPLA2 | Group IIA phospholipase A2 | NPS-PLA2 | Non-Pancreatic Secretory Phospholipase A2 | Non-pancreatic secretory phospholipase A2 (hnps-PLA2) | PA2GA_HUMAN | PLA2B | PLA2G2A | PLA2L | Phosphatidylcholine 2-acylhydrolase | Phospholipase A2 group IIA | RASF-A
Type:
Hydrolase
Mol. Mass.:
16101.20
Organism:
Homo sapiens (Human)
Description:
The human nps PLA2 was cloned, and expressed in E. coli. There was a refolding process in the purification.
Residue:
144
Sequence:
MKTLLLLAVIMIFGLLQAHGNLVNFHRMIKLTTGKEAALSYGFYGCHCGVGGRGSPKDATDRCCVTHDCCYKRLEKRGCGTKFLSYKFSNSGSRITCAKQDSCRSQLCECDKAAATCFARNKTTYNKKYQYYSNKHCRGSTPRC
  
Inhibitor
Name:
BDBM23753
Synonyms:
3-{4-[(4-octadecylpiperazin-1-yl)methyl]phenyl}-4,5-dihydro-1,2,4-oxadiazol-5-one | PMS 1062 piperazine deriv., 23c
Type:
Small organic molecule
Emp. Form.:
C31H52N4O2
Mol. Mass.:
512.7702
SMILES:
CCCCCCCCCCCCCCCCCCN1CCN(Cc2ccc(cc2)-c2nc(=O)o[nH]2)CC1
Structure:
Search PDB for entries with ligand similarity:
Substrate
Name:
BDBM23751
Synonyms:
1-hexadecanoyl-2-(10-pyrenyldecanoyl)-sn-glycero-3-phosphoglycerol | 1-palmitoyl-2-(10-pyrenyldecanoyl)-sn-glycero-3-phosphorylcholine | beta-pyC-10-PG
Type:
fluorescent phospholipid probe
Emp. Form.:
n/a
Mol. Mass.:
n/a
SMILES:
n/a
Structure: